January 14, 2026 - 04:36

HOUSTON, January 13, 2026—Codenotary, a pioneer in software supply chain security, has announced a significant milestone with the granting of a U.S. patent for its groundbreaking technology that enhances data integrity verification on a large scale. This innovative approach to cryptographic proof is set to transform the way enterprises validate the integrity of their data, addressing a critical need in today's digital landscape.
The patented technology offers a swift and efficient method for enterprises to ensure that their data remains unaltered and trustworthy. By streamlining the verification process, Codenotary's solution not only boosts operational efficiency but also fortifies the security of software supply chains—a vital aspect as cyber threats continue to evolve.
This achievement underscores Codenotary's commitment to advancing security measures in the software industry, providing organizations with the tools they need to safeguard their digital assets effectively. As businesses increasingly rely on complex software ecosystems, this patented technology positions Codenotary as a leader in the realm of data integrity verification.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...